Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1ion Sep 18, 2023 8:27am
248 Views
Post# 35640965

RE:CBD

RE:CBDDengue on the wild in Cambodia, Bangladesh and India (a BRICS country member).   Headline from article regarding India.  Emerging countries with poorer regions need effective and more cost effective anti-virals and those can be obtained from cannabinoid compounds and of importance is not just CBD but certain terpenes.   Dengue is getting bad and it won't be long before mosquitoes in the southern parts of North America will be carrying it.   Then it can spread to other animals with a greater range of habitat northward.    

India continues to grapple with Dengue and its complications; Here’s what we know so far

Dengue Outbreak in India: According to Dr. Tayal, the initial symptoms of dengue are high-grade fever, headache, pain behind the eyes, nausea, and joint pain which last for approximately 5 days.


<< Previous
Bullboard Posts
Next >>